SEARCH

SEARCH BY CITATION

References

  • Aarnio M., Mecklin J.P., Aaltonen L.A., Nystrom-Lahti M. & Jarvinen H.J. (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. International Journal of Cancer 64, 430433.
  • Aktan-Collan K., Mecklin J.P., Jarvinen H., Nystrom-Lahti M., Peltomaki P., Soderling I., Uutela A., De La Chapelle A. & Kaariainen H. (2000) Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. International Journal of Cancer 89, 4450.
  • Aktan-Collan K., Haukkala A., Mecklin J.P., Uutela A. & Kaariainen H. (2001) Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. International Journal of Cancer 93, 608611.
  • American Society of Clinical Oncology (2003) Policy Statement Update: Genetic Testing for Cancer Susceptibility. Retrieved from http://www.jco.org/cgi/content/abstract/JCO.2003.03.189v1?ck=nck on 10 July 2009.
  • Andrews L., Meiser B., Apicella C. & Tucker K. (2004) Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genetic Testing 8, 240247.
  • Andrykowski M.A., Munn R.K. & Studts J.L. (1996) Interest in learning of personal genetic risk for cancer: a general population survey. Preventive Medicine 25, 527536.
  • Association of British Insurers (2008). Retrieved from http://www.abi.org.uk/ on 8 August 2008.
  • Billings P. & Beckwith J. (1992) Genetic testing in the workplace: a view from the USA. Trends in Genetics 8, 198202.
  • Bonadona V., Saltel P., Desseigne F., Mignotte H., Saurin J.C., Wang Q., Sinilnikova O., Giraud S., Freyer G., Plauchu H., Puisieux A. & Lasset C. (2002) Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers and Prevention 11, 97104.
  • Botkin J.R., Smith K.R., Croyle R.T., Baty B.J., Wylie J.E., Dutson D., Chan A., Hamann H.A., Lerman C., McDonald J., Venne V., Ward J.H. & Lyon E. (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics A 118, 201209.
  • Brain K., Gray J., Norman P., Parsons E., Clarke A., Rogers C., Mansel R. & Harper P. (2000) Why do women attend familial breast cancer clinics? Journal of Medical Genetics 37, 197202.
  • Bratt O., Kristoffersson U., Lundgren R. & Olsson H. (1997) Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 50, 360365.
  • Bratt O., Damber J.E., Emanuelsson M., Kristoffersson U., Lundgren R., Olsson H. & Gronberg H. (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer 36, 235241.
  • Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute 91, 13101316.
  • Bruno M., Tommasi S., Stea B., Quaranta M., Schittulli F., Mastropasqua A., Distante A., Di Paola L. & Paradiso A. (2004) Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Annals of Oncology 15, I48I54.
  • Burke W. (2004) Genetic testing in primary care. Annual Review of Genomics and Human Genetics 5, 114.
  • Calzone K.A. (1997) Genetic predisposition testing: clinical implications for oncology nurses. Oncology Nurses Forum 24, 712718.
  • Cappelli M., Surh L., Humphreys L., Verma S., Logan D., Hunter A. & Allanson J. (1999) Psychological and social determinants of women’s decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics 55, 419430.
  • Chaliki H., Loader S., Levenkron J.C., Logan-Young W., Hall W.J. & Rowley P.T. (1995) Women’s receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health 85, 11331135.
  • Claes E., Denayer L., Evers-Kiebooms G., Boogaerts A. & Legius E. (2004) Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Education and Counselling 55, 265274.
  • Codori A.M., Petersen G.M., Miglioretti D.L., Larkin E.K., Bushey M.T., Young C., Brensinger J.D., Johnson K., Bacon J.A. & Booker S.V. (1999) Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers and Prevention 8, 345351.
  • Collins J.A. & Fauser B.C.J.M. (2005) Balancing the strengths of systematic and narrative reviews. Human Reproduction Update 11, 103104.
  • Cormier L., Valeri A., Azzouzi R., Fournier G., Cussenot O., Berthon P., Guillemin F. & Mangin P. (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51, 276285.
  • Croyle R.T. & Lerman C. (1993) Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Preventive Medicine 22, 284292.
  • Croyle R.T., Smith K.R., Botkin J.R., Baty B. & Nash J. (1997) Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychology 16, 6372.
  • Davison C., Macintyre S. & Smith G.D. (1994) The potential social impact of predictive genetic testing for susceptibility to common chronic diseases: a review and proposed research agenda. Sociology of Health and Illness 16, 340371.
  • Department of Health (2000) The NHS Cancer Plan: A Plan for Investment, a Plan for Reform. Department of Health, London, UK.
  • Department of Health (2003) Our Inheritance, our Future: Realising the Potential of Genetics in the NHS. Department of Health, London, UK.
  • Diefenbach M.A., Schnoll R.A., Miller S.M. & Brower L. (2000) Genetic testing for prostate cancer. Willingness and predictors of interest. Cancer Practice 8, 8286.
  • Van Dooren S., Seynaeve C., Rijnsburger A., Duivenvoorden H., Essink-Bot M.L., Bartels C., Klijn J., Koning H. & Tibben A. (2005) The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer. Breast Cancer Research and Treatment 89, 7580.
  • Durfy S.J., Bowen D.J., McTiernan A., Sporleder J. & Burke W. (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology, Biomarkers and Prevention 8, 369375.
  • Easton D.F. & Eeles R.A. (2008) Genome-wide association studies in cancer. Human Molecular Genetics 17, R109R115.
  • Eeles R.A. (2000) Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research 2, 283290.
  • EelesR.A., EastonD.F., PonderB.A.J. & EngC., Editors (2004) Genetic Predisposition to Cancer, 2nd edn: Arnold, London, UK.
  • EuroGentest (2009) Harmonising Genetic Testing Across Europe. Retrieved from http://www.eurogentest.org/ on 10 July 2009.
  • European Commission Joint Research Centre (2003) Towards Quality Assurance and Harmonisation of Genetic Testing Services in the EU. Retrieved from http://www.jrc.es/home/pages/detail.cfm?prs=1124 on 10 July 2009.
  • Forrest K., Simpson S.A., Wilson B.J., Van Teijlingen E.R., McKee L., Haites N. & Matthews E. (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Genetics 64, 317326.
  • Foster C., Watson M., Eeles R., Eccles D., Ashley S., Davidson R., Mackay J., Morrison P.J., Hopwood P., Evans D.G. & Psychosocial Study Collaborators (2007) Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. British Journal of Cancer 96, 718724.
  • Gaff C.L., Clarke A.J., Atkinson P., Sivell S., Elwyn G., Iredale R., Thornton H., Dundon J., Shaw C. & Edwards A. (2007) Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics 10, 9991011.
  • Glanz K., Grove J., Lerman C., Gotay C. & Le Marchand L. (1999) Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers and Prevention 8, 329336.
  • Hadley D.W., Jenkins J., Dimond E., Nakahara K., Grogan L., Liewehr D.J., Steinberg S.M. & Kirsch I. (2003) Genetic counseling and testing in families with hereditary non polyposis colorectal cancer. Archives of Internal Medicine 163, 573582.
  • Hallowell N., Foster C., Eeles R., Ardern-Jones A., Murday V. & Watson M. (2003) Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. Journal of Medical Ethics 29, 7479.
  • Hallowell N., Foster C., Eeles R., Ardern-Jones A. & Watson M. (2004) Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Social Science in Medicine 59, 553565.
  • Hallowell N., Ardern-Jones A., Eeles R., Foster C., Lucassen A., Moynihan C. & Watson M. (2005) Men’s decision-making about predictive BRCA1/2 testing: the role of family. Journal of Genetic Counselling 14, 207217.
  • Human Genetic Society of Australasia (2002) DNA Presymptomatic and Predictive Testing for Genetic Disorders. Retrieved from http://www.hgsa.com.au/ on 10 July 2009.
  • Javitt G.H. & Hudson K. (2007) The right prescription for personalized genetic medicine. Personalized Medicine 4, 115118.
  • Julian-Reynier C., Eisinger F., Chabal F., Aurran Y., Bignon Y.J., Nogues C., Machelard M., Maugard C., Vennin P. & Sobol H. (1998) Cancer genetic clinics: why do women who already have cancer attend? European Journal of Cancer 34, 15491553.
  • Julian-Reynier C., Sobol H., Sevilla C., Nogues C. & Bourret P. (2000) Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psycho-oncology 9, 504510.
  • Kash K.M., Holland J.C., Halper M.S. & Miller D.G. (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute 84, 2430.
  • Kinney A.Y., Choi Y.A., DeVellis B., Kobetz E., Millikan R.C. & Sandler R.S. (2000) Interest in genetic testing among first-degree relatives of colorectal cancer patients. American Journal of Preventive Medicine 18, 249252.
  • Lango H. & Weedon M.N. (2008) What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice? Journal of Internal Medicine 263, 1627.
  • Lerman C. & Shields A.E. (2004) Genetic testing for cancer susceptibility: the promise and the pitfalls. Nature Reviews Cancer 4, 235241.
  • Lerman C., Daly M., Masny A. & Balshem A. (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology 12, 843850.
  • Lerman C., Marshall J., Audrain J. & Gomez-Caminero A. (1996a) Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. International Journal of Cancer 69, 5861.
  • Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., Bonney G., Gold K., Trock B., Main D., Lynch J., Fulmore C., Snyder C., Lemon S.J., Conway T., Tonin P., Lenoir G. & Lynch H. (1996b) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Journal of the American Medical Association 275, 18851892.
  • Lerman C., Hughes C., Trock B.J., Myers R.E., Main D., Bonney A., Abbaszadegan M.R., Harty A.E., Franklin B.A., Lynch J.F. & Lynch H.T. (1999) Genetic testing in families with hereditary non polyposis colon cancer. Journal of the American Medical Association 281, 16181622.
  • Lerman C., Hughes C., Croyle R.T., Main D., Durham C., Snyder C., Bonney A., Lynch J.F., Narod S.A. & Lynch H.T. (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine 31, 7580.
  • Lerman C., Croyle R.T., Tercyak K.P. & Hamann H. (2002) Genetic testing: psychological aspects and implications. Journal of Consultations in Clinical Psychology 70, 784797.
  • Li Y. & Doukas D.J. (2004) Health motivation and emotional vigilance in genetic testing for prostate cancer risk. Clinical Genetics 66, 512516.
  • Liede A., Metcalfe K., Hanna D., Hoodfar E., Snyder C., Durham C., Lynch H.T. & Narod S.A. (2000) Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics 67, 14941504.
  • Lipkus I.M., Iden D., Terrenoire J. & Feaganes J.R. (1999) Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 8, 533539.
  • Loader S., Shields C.G. & Rowley P.T. (2004) Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing 8, 112.
  • Lodder L., Frets P.G., Trijsburg R.W., Meijers-Heijboer E.J., Klijn J.G., Duivenvoorden H.J., Tibben A., Wagner A., Van Der Meer C.A., Van Den Ouweland A.M. & Niermeijer M.F. (2001) Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics 98, 1524.
  • Lynch H.T., Snyder C., Lynch J.F., Karatoprakli P., Trowonou A., Metcalfe K., Narod S.A. & Gong G. (2006) Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genetics and Cytogenetics 165, 9197.
  • Meijers-Heijboer E.J., Verhoog L.C., Brekelmans C.T., Seynaeve C., Tilanus-Linthorst M.M., Wagner A., Dukel L., Devilee P., Van Den Ouweland A.M., Van Geel A.N. & Klijn J.G. (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355, 20152020.
  • Meiser B. (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-oncology 14, 10601074.
  • Meiser B., Butow P., Barratt A., Suthers G., Smith M., Colley A., Thompson E. & Tucker K. (2000) Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer. Journal of Medical Genetics 37, 472476.
  • Meiser B., Butow P., Friedlander M., Barratt A., Schnieden V., Watson M., Brown J. & Tucker K. (2002) Psychological impact of genetic testing in women from high-risk breast cancer families. European Journal of Cancer 38, 20252031.
  • Meiser B., Collins V., Warren R., Gaff C., St John D.J., Young M.A., Harrop K., Brown J. & Halliday J. (2004) Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clinical Genetics 66, 502511.
  • Miesfeldt S., Jones S.M., Cohn W., Lippert M., Haden K., Turner B.L., Martin-Fries T. & Clark S.M. (2000) Men’s attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 55, 4650.
  • Myers R.E., Hyslop T., Jennings-Dozier K., Wolf T.A., Burgh D.Y., Diehl J.A., Lerman C. & Chodak G.W. (2000) Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiology, Biomarkers and Prevention 9, 13231328.
  • National Institute for Health and Clinical Excellence (2006) Familial Breast Cancer the Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary care (NICE Guideline). National Institute for Health and Clinical Excellence. Retrieved from http://www.nice.org.uk on 10 June 2007.
  • Nelkin (1992) The social power of genetic information. In The Code of Codes (KelvesD.J. & HoodL., eds), Harvard University Press, Cambridge, MA, pp. 177190.
  • Van Oostrom I., Meijers-Heijboer H., Duivenvoorden H.J., Brocker-Vriends A.H., Van Asperen C.J., Sijmons R.H., Seynaeve C., Van Gool A.R., Klijn J.G. & Tibben A. (2006) Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Annals of Oncology 17, 10901095.
  • Van Oostrom I., Meijers-Heijboer H., Duivenvoorden H.J., Brocker-Vriends A.H., Van Asperen C.J., Sijmons R.H., Seynaeve C., Van Gool A.R., Klijn J.G., Riedijk S.R., Van Dooren S. & Tibben A. (2007) A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psycho-oncology 16, 320328.
  • Patenaude A.F. (1996) The genetic testing of children for cancer susceptibility: ethical, legal, and social issues. Behavioural Sciences and the Law 14, 393410.
  • Pearson H. (2008) Genetic testing for everyone. Nature 453, 570571.
  • Peterson E.A., Milliron K.J., Lewis K.E., Goold S.D. & Merajver S.D. (2002) Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers and Prevention 11, 7987.
  • Pharoah P.D., Antoniou A.C., Easton D.F. & Ponder B.A. (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. New England Journal of Medicine 358, 27962803.
  • Ponder M. & Green J. (1996) BRCA1 testing: some issues in moving from research to service. Psycho-oncology 5, 223232.
  • Reichelt J.G., Heimdal K., Moller P. & Dahl A.A. (2004) BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Family Cancer 3, 2128.
  • Van Roosmalen M.S., Stalmeier P.F., Verhoef L.C., Hoekstra-Weebers J.E., Oosterwijk J.C., Hoogerbrugge N., Moog U. & Van Daal W.A. (2004) Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics A 124, 346355.
  • Rose A.L., Peters N., Shea J.A. & Armstrong K. (2005) Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genetics 8, 145151.
  • Sanderson S.C., Wardle J., Jarvis M.J. & Humphries S.E. (2004) Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Preventive Medicine 39, 458464.
  • Scheuer L., Kauff N., Robson M., Kelly B., Barakat R., Satagopan J., Ellis N., Hensley M., Boyd J., Borgen P., Norton L. & Offit K. (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology 20, 12601268.
  • Schwartz M.D., Lerman C., Miller S.M., Daly M. & Masny A. (1995) Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychology 14, 232235.
  • Schwartz M.D., Peshkin B.N., Hughes C., Main D., Isaacs C. & Lerman C. (2002) Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology 20, 514520.
  • Shaw J.S. & Bassi K.L. (2001) Lay attitudes toward genetic testing for susceptibility to inherited diseases. Journal of Health Psychology 6, 405423.
  • Singer P.A. & Daar A.S. (2001) Harnessing genomics and biotechnology to improve global health equity. Science 294, 22892290.
  • Smith K.R. & Croyle R.T. (1995) Attitudes toward genetic testing for colon cancer risk. American Journal of Public Health 85, 14351438.
  • Struewing J.P., Lerman C., Kase R.G., Giambarresi T.R. & Tucker M.A. (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers and Prevention 4, 169173.
  • Tambor E.S., Rimer B.K. & Strigo T.S. (1997) Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. American Journal of Medical Genetics 68, 4349.
  • The Genetic Information Nondiscrimination Act (2008). Retrieved from http://www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/GINAInfoDoc.pdf on 20th October 2009.
  • The National Coalition for Health Professional Education in Genetics (2009). Retrieved from http://www.nchpeg.org on 10 July 2009.
  • The National Genetics Education and Development Centre (2009). Retrieved from http://www.geneticseducation.nhs.uk on 10 July 2009.
  • Thompson D. & Easton D.F. (2002) Cancer incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute 94, 13581365.
  • Watson M., Foster C., Eeles R., Eccles D., Ashley S., Davidson R., Mackay J., Morrison P.J., Hopwood P. & Evans D.G. (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer 91, 17871794.
  • Wellisch D.K., Gritz E.R., Schain W., Wang H.J. & Siau J. (1991) Psychological functioning of daughters of breast cancer patients. Part I: Daughters and comparison subjects. Psychosomatics 32, 324336.
  • Wilson B.J., Forrest K., Van Teijlingen E.R., McKee L., Haites N., Matthews E. & Simpson S.A. (2004) Family communication about genetic risk: the little that is known. Community Genetics 7, 1524.
  • World Health Organisation (2000) Statement of the WHO Expert Consultation on New Developments in Human Genetics. Retrieved from http://www.whqlibdoc.who.int/hq/2000/WHO_HGN_WG_00.3.pdf on 20th October 2009.
  • World Medical Association (2005). Statement on Genetics and Medicine. Retrieved from http://www.wma.net/e/policy/g11.htm on 20th October 2009.
  • Zheng S.L., Sun J., Wiklund F., Smith S., Stattin P., Li G., Adami H.O., Hsu F.C., Zhu Y., Balter K., Kader A.K., Turner A.R., Liu W., Bleecker E.R., Meyers D.A., Duggan D., Carpten J.D., Chang B.L., Isaacs W.B., Xu J. & Gronberg H. (2007) Cumulative association of five genetic variants with prostate cancer. New England Journal of Medicine 358, 910919.